Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Selective hydroboration of dieneamines. Formation of hydroxyalkylphenothiazines as MDR modulators.

Takács D, Nagy I, Bombicz P, Egyed O, Jemnitz K, Riedl Z, Molnár J, Amaral L, Hajós G.

Bioorg Med Chem. 2012 Jul 15;20(14):4258-70. doi: 10.1016/j.bmc.2012.05.065. Epub 2012 Jun 5.

PMID:
22739092
2.

Synthesis and pharmacological investigation of new N-hydroxyalkyl-2-aminophenothiazines exhibiting marked MDR inhibitory effect.

Takács D, Egyed O, Drahos L, Szabó P, Jemnitz K, Szabó M, Veres Z, Visy J, Molnár J, Riedl Z, Hajós G.

Bioorg Med Chem. 2013 Jul 1;21(13):3760-79. doi: 10.1016/j.bmc.2013.04.034. Epub 2013 Apr 23.

PMID:
23673221
3.

New phenothiazine-type multidrug resistance modifiers: anti-MDR activity versus membrane perturbing potency.

Hendrich AB, Wesołowska O, Motohashi N, Molnár J, Michalak K.

Biochem Biophys Res Commun. 2003 May 2;304(2):260-5.

PMID:
12711308
4.

Phenothiazines and structurally related compounds as modulators of cancer multidrug resistance.

Tsakovska I, Pajeva I.

Curr Drug Targets. 2006 Sep;7(9):1123-34. Review.

PMID:
17017890
5.

Inhibition of P-glycoprotein transport function by N-acylphenothiazines.

Wesolowska O, Molnár J, Motohashi N, Michalak K.

Anticancer Res. 2002 Sep-Oct;22(5):2863-7.

PMID:
12530010
6.

Interactions of phenothiazines with lipid bilayer and their role in multidrug resistance reversal.

Michalak K, Wesolowska O, Motohashi N, Molnar J, Hendrich AB.

Curr Drug Targets. 2006 Sep;7(9):1095-105. Review.

PMID:
17017888
7.

QSAR and 3D-QSAR of phenothiazine type multidrug resistance modulators in P388/ADR cells.

Tsakovska IM.

Bioorg Med Chem. 2003 Jul 3;11(13):2889-99.

PMID:
12788359
8.
10.

Synthesis and biochemical characterization of new phenothiazines and related drugs as MDR reversal agents.

Schmidt M, Teitge M, Castillo ME, Brandt T, Dobner B, Langner A.

Arch Pharm (Weinheim). 2008 Oct;341(10):624-38. doi: 10.1002/ardp.200800115.

PMID:
18816589
11.

Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives.

Bisi A, Meli M, Gobbi S, Rampa A, Tolomeo M, Dusonchet L.

Bioorg Med Chem. 2008 Jul 1;16(13):6474-82. doi: 10.1016/j.bmc.2008.05.040. Epub 2008 May 20.

PMID:
18522868
12.

Heterogeneous dehydrocoupling of amine-borane adducts by skeletal nickel catalysts.

Robertson AP, Suter R, Chabanne L, Whittell GR, Manners I.

Inorg Chem. 2011 Dec 19;50(24):12680-91. doi: 10.1021/ic201809g. Epub 2011 Nov 21.

PMID:
22103654
13.

Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells.

Molnár J, Hevér A, Fakla I, Fischer J, Ocsovski I, Aszalós A.

Anticancer Res. 1997 Jan-Feb;17(1A):481-6.

PMID:
9066699
14.

Neither lipophilicity nor membrane-perturbing potency of phenothiazine maleates correlate with the ability to inhibit P-glycoprotein transport activity.

Hendrich AB, Wesołowska O, Poła A, Motohashi N, Molnár J, Michalak K.

Mol Membr Biol. 2003 Jan-Mar;20(1):53-60.

PMID:
12745926
15.

Bis-pyranobenzoquinones as a new family of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in mammalian cells and the protozoan parasite Leishmania.

Jiménez-Alonso S, Pérez-Lomas AL, Estévez-Braun A, Muñoz Martinez F, Chávez Orellana H, Ravelo AG, Gamarro F, Castanys S, López M.

J Med Chem. 2008 Nov 27;51(22):7132-43. doi: 10.1021/jm800403b.

PMID:
18954040
16.

Discovery of pyridine-2-ones as novel class of multidrug resistance (MDR) modulators: first structure-activity relationships.

Krawczyk S, Otto M, Otto A, Coburger C, Krug M, Seifert M, Tell V, Molnár J, Hilgeroth A.

Bioorg Med Chem. 2011 Nov 1;19(21):6309-15. doi: 10.1016/j.bmc.2011.09.005. Epub 2011 Sep 10.

PMID:
21964185
17.

Analogs of a 4-aminothieno[2,3-d]pyrimidine lead (QB13) as modulators of P-glycoprotein substrate specificity.

Häcker HG, de la Haye A, Sterz K, Schnakenburg G, Wiese M, Gütschow M.

Bioorg Med Chem Lett. 2009 Nov 1;19(21):6102-5. doi: 10.1016/j.bmcl.2009.09.023. Epub 2009 Sep 11.

PMID:
19783433
18.

Synthesis and biological evaluation of a small molecule library of 3rd generation multidrug resistance modulators.

Klinkhammer W, Müller H, Globisch C, Pajeva IK, Wiese M.

Bioorg Med Chem. 2009 Mar 15;17(6):2524-35. doi: 10.1016/j.bmc.2009.01.072. Epub 2009 Feb 5.

PMID:
19250834
19.

Synthesis, structure, and stability of adducts between phosphide and amide anions and the Lewis acids borane, tris(pentafluorophenyl)borane, and tris(pentafluorophenyl)alane.

Fuller AM, Mountford AJ, Scott ML, Coles SJ, Horton PN, Hughes DL, Hursthouse MB, Lancaster SJ.

Inorg Chem. 2009 Dec 7;48(23):11474-82. doi: 10.1021/ic901799q.

PMID:
19863118
20.

Design, synthesis, and evaluation of new chemosensitizers in multi-drug-resistant Plasmodium falciparum.

Guan J, Kyle DE, Gerena L, Zhang Q, Milhous WK, Lin AJ.

J Med Chem. 2002 Jun 20;45(13):2741-8.

PMID:
12061877

Supplemental Content

Support Center